Camp4 Therapeutics (CAMP) Total Liabilities (2023 - 2026)

Camp4 Therapeutics has disclosed Total Liabilities across 4 years of filings, most recently posting $74.6 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $74.6 million, up 565.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $74.6 million (up 565.61% YoY), and the FY2025 annual result was $70.1 million, up 362.34% from the prior year.
• Total Liabilities came in at $74.6 million for Q1 2026 at Camp4 Therapeutics, up from $70.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $147.1 million in Q2 2024 to a low of $11.2 million in Q1 2025.
• The 4-year median for Total Liabilities is $27.7 million (2025), against an average of $58.1 million.
• Across the five-year window, Total Liabilities tumbled 92.33% in 2025 and surged 565.61% in 2026, its largest moves.
• Camp4 Therapeutics' Total Liabilities stood at $16.5 million in 2023, then slipped by 8.26% to $15.2 million in 2024, then soared by 362.34% to $70.1 million in 2025, then rose by 6.35% to $74.6 million in 2026.
• The last three Total Liabilities figures came in at $74.6 million (Q1 2026), $70.1 million (Q4 2025), and $27.7 million (Q3 2025), per Business Quant data.